Homepage
Top Stories
More News
Qinecsa Solutions announce acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions
Qinseca Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, has announced its acquisition of Insife ApS, a Danish-based software, technology and consultancy firm specialising in developing pharamacovigilance platforms. Read more
15 Apr 2024
Health Tech Solutions Group announces official UK launch
Health Tech Solutions Group, a healthcare provider, has announced its official UK launch. The company offers healthcare solutions, including mobile health services, telemedicine, and personalised patient care outside traditional hospital settings. Read more
15 Apr 2024
blueBrix platform unveils micro frontends and analytics for Patient Support Program & Remote Patient Monitoring Modules
A leading DevOps platform for digital health, blueBrix, has unveiled new micro frontends for its Patient Support Program and Remote Patient Monitoring Modules. Read more
12 Apr 2024
Med-Tech Innovation Expo News
The health and wealth at Med-Tech Innovation Expo
The Med-Tech Innovation Conference this year will include two high-end keynote sessions. With the programme now taking shape, we can give you some insight as to what you can expect on 5-6th June at the NEC. Read more
15 Mar 2024
Call for papers opens for Med-Tech Innovation Expo 2024
Applications are now open for speakers to take part in the world-leading conference programme which runs alongside Med-Tech Innovation Expo, on 5th-6th June 2024, at the NEC, Birmingham. Read more
2 Oct 2023
Med-Tech Innovation Expo 2024: Registration now open!
Registration has opened for Med-Tech Innovation Expo 2024, the UK & Ireland’s leading event for medical device manufacturing, taking place on 5-6 June at the NEC in Birmingham. Read more
3 Jan 2024
Sponsored
What are you waiting for?
Thomas Averre is a Director at Tarleton Communications, a specialist life sciences public relations agency. Read more
Latest News
17 Apr 2024
16 Apr 2024